Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial reactive oxygen species (ROS)-generating machinery is a complex system primarily comprising the electron transport chain (ETC) complexes, notably Complex I (NADH:ubiquinone oxidoreductase) and Complex III (ubiquinol:cytochrome c oxidoreductase), which are the principal sites of superoxide production (PMID: 28213294). Under normal physiological conditions, these ROS act as vital signaling molecules for cellular processes such as differentiation and adaptation to stress; however, their dysregulation leads to oxidative stress, causing damage to mitochondrial DNA, proteins, and lipids (PMID: 24561009). This oxidative damage is a key driver in the progression of various diseases, including neurodegenerative disorders like Parkinson's and Alzheimer's, cardiovascular diseases, and metabolic syndromes (PMID: 25644350). Therapeutic interventions targeting this machinery include mitochondria-targeted antioxidants like MitoQ and SkQ1, which are designed to accumulate in the mitochondrial matrix and neutralize ROS at their source, as well as compounds like elamipretide that stabilize mitochondrial membranes (PMID: 21030111). While promising, targeting this system requires precision to avoid inhibiting essential energy production and physiological redox signaling, which can result in mitochondrial toxicity (PMID: 28213294).
Mitochondria-targeted antioxidant scavenging of superoxide, modulation of electron transport chain activity to reduce electron leakage, and stabilization of mitochondrial membrane lipids like cardiolipin.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial reactive oxygen species-generating machinery (mROS machinery).